trending Market Intelligence /marketintelligence/en/news-insights/trending/nxz6qidrc4ex0foca2t1ug2 content esgSubNav
In This List

Checkpoint Therapeutics appoints board member

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Checkpoint Therapeutics appoints board member

Checkpoint Therapeutics Inc. added Christian Béchon to its board.

Béchon is the chairman and CEO of Paris-based ChB Consultants, a privately held life science consultancy company.

Prior to ChB, he was the chairman and CEO of LFB SA, a French biopharmaceutical company that specializes in biological medicinal products for treating serious and rare disorders.

New York-based Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company that develops treatments for patients with solid tumor cancers.